Back to Authors

Jacobus Ambuludi, Egon J

Mayo Clinic

Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Citations 1

Impaired β-cell glucokinase as an underlying mechanism in diet-induced diabetes
Lu, Brian , Kurmi, Kiran , Munoz-Gomez, Miguel, Jacobus, Egon J. , Tonne, Jason M., Rakshit, Kuntol, Hitosugi, Taro , Kudva, Yogish C. , Matveyenko, Aleksey V. , Ikeda, Yasuhiro , Jacobus Ambuludi, Egon J

Disease Models & Mechanisms | June 13, 2018 | Volume: 11 | Issue: 6 | Pages: No page available

10.1242/dmm.033316 Get It

ABSTRACT High-fat diet (HFD)-fed mouse models have been widely used to study early type 2 diabetes. Decreased β-cell glucokinase (GCK) expression has been observed in HFD-induced diabetes. However, owing to its crucial roles in glucose metabolism in the liver and in islet β-cells, the contribution of decreased GCK expression to the development of HFD-induced diabetes is unclear. Here, we employed a β-cell-targeted gene transfer vector and determined the impact of β-cell-specific increase in GCK expression on β-cell function and glucose handling in vitro and in vivo. Overexpression of GCK enhanced glycolytic flux, ATP-sensitive potassium channel activation and membrane depolarization, and increased proliferation in Min6 cells. β-cell-targeted GCK transduction did not change glucose handling in chow-fed C57BL/6 mice. Although adult mice fed a HFD showed reduced islet GCK expression, impaired glucose tolerance and decreased glucose-stimulated insulin secretion (GSIS), β-cell-targeted GCK transduction improved glucose tolerance and restored GSIS. Islet perifusion experiments verified restored GSIS in isolated HFD islets by GCK transduction. Thus, our data identify impaired β-cell GCK expression as an underlying mechanism for dysregulated β-cell function and glycemic control in HFD-induced diabetes. Our data also imply an etiological role of GCK in diet-induced diabetes. This article has an associated First Person interview with the first author of the paper.